Stryker set to buy Pfizer's Howmedica for $1.9 billion
This article was originally published in Clinica
Executive Summary
Stryker Corporation, the US surgical and orthopaedic company is to become the new owner of Pfizer's Howmedica division at a reported price of $1.9 billion - more than twice Howmedica's annual $820 million turnover.